William Barba, MD
Urology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 40 years
- Graduated 1986
Offices
1 location · Los Angeles Urology Medical Group Inc · 2 clinicians in this group
Hospitals listed: Adventist Health White Memorial. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barba’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health White MemorialLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health White Memorial
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.29) · 473 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.58 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.08 (101.25 to 214.92) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 163 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,433 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,215 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,320 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (0.46 to 5.23) · 632 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.58) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.96 (2.37 to 19.55) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.48 to 9.73) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.45 (0 to 1.22) · 2,746 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 207 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.403 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.034 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.673 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.803 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 257 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 517 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -34.6 · 74 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -21.5 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4 · 208 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 497 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 218 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9 to 16.4) · 199 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 51 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,008 patients answered, 10% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$109,374
Medicare paid this office $109,374 for 138 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 116 | $45,709 | $146 |
| Complete ultrasound scan of abdomen | 124 | $23,274 | $91 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 32 | $11,332 | $324 |
| Assessment of muscle signal of pelvic nerves | 28 | $6,594 | $236 |
| New patient visit (60+ min) | 31 | $5,595 | $180 |
See all 8 services
| Long return visit (40+ min) | 116 | $45,709 | $146 |
| Complete ultrasound scan of abdomen | 124 | $23,274 | $91 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 32 | $11,332 | $324 |
| Assessment of muscle signal of pelvic nerves | 28 | $6,594 | $236 |
| New patient visit (60+ min) | 31 | $5,595 | $180 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 35 | $1,258 | $31 |
| Manual urinalysis test with examination using microscope, automated | 124 | $927 | $3 |
| Electronic assessment of bladder emptying | 39 | $276 | $7 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Electronic assessment of bladder emptying | 111 | 86 | 77 | 77 | 70 | 42 |
| Assessment of muscle signal of pelvic nerves | 110 | 47 | 51 | 39 | 54 | 28 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 17 | 78 | 67 | 63 | 57 | 41 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | – | 50 | 58 | 63 | 56 | 35 |
| Simple bladder irrigation and/or instillation | 14 | 14 | – | – | – | – |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 15 | 12 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
138 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 9% · Women 21% · Health risk score 1.83. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 57% · Chronic kidney disease 36% · Coronary heart disease 29% · Depression 28% · Heart failure 25% · Cancer 15% · COPD 15% · Atrial fibrillation 13% · Dementia 12% · Stroke 9%.
The office billed $252,494, Medicare allowed $146,154 and paid $109,374; for 1,151 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 138 | 1,151 | 73 | 1.83 | $252,494 | $109,374 |
| 2023 | 145 | 1,473 | 73 | 1.95 | $334,702 | $138,767 |
| 2022 | 135 | 1,508 | 73 | 2.05 | $353,342 | $152,828 |
| 2021 | 171 | 1,782 | 73 | 1.94 | $369,998 | $167,815 |
| 2020 | 198 | 2,317 | 74 | 1.90 | $417,275 | $172,352 |
| 2019 | 255 | 2,559 | 75 | 2.00 | $496,565 | $199,004 |
| 2018 | 228 | 2,979 | 73 | 2.30 | $529,220 | $204,289 |
| 2017 | 266 | 3,166 | 74 | 2.19 | $671,860 | $243,265 |
| 2016 | 354 | 2,609 | 72 | 2.08 | $614,260 | $242,802 |
| 2015 | 350 | 2,326 | 72 | 2.05 | $569,280 | $224,420 |
| 2014 | 489 | 3,236 | 73 | 2.01 | $705,735 | $292,434 |
| 2013 | 567 | 4,148 | 72 | 1.92 | $783,840 | $327,951 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Long return visit (40+ min) | 136 | $58,070 | $144 |
| Complete ultrasound scan of abdomen | 129 | $24,625 | $91 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 45 | $18,166 | $324 |
| Assessment of muscle signal of pelvic nerves | 51 | $11,309 | $209 |
| New patient visit (60+ min) | 28 | $4,925 | $176 |
| Dilation of urethra using an endoscope | 11 | $3,526 | $294 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 46 | $1,471 | $26 |
| Manual urinalysis test with examination using microscope, automated | 134 | $1,179 | $3 |
| Testing for presence of drug, read by direct observation | 40 | $667 | $12 |
| Electronic assessment of bladder emptying | 57 | $489 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 12 | $0 | None |
2022: 8 services
| Long return visit (40+ min) | 118 | $63,270 | $154 |
| Complete ultrasound scan of abdomen | 119 | $32,983 | $100 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 50 | $21,004 | $333 |
| Assessment of muscle signal of pelvic nerves | 35 | $10,075 | $258 |
| New patient visit (60+ min) | 35 | $6,339 | $181 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 50 | $1,696 | $27 |
| Manual urinalysis test with examination using microscope, automated | 121 | $1,232 | $3 |
| Electronic assessment of bladder emptying | 60 | $515 | $7 |
2021: 11 services
| Long return visit (40+ min) | 141 | $50,596 | $152 |
| Complete ultrasound scan of abdomen | 129 | $39,825 | $111 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 45 | $20,106 | $347 |
| Return visit (30+ min) | 78 | $14,453 | $103 |
| Assessment of muscle signal of pelvic nerves | 48 | $13,001 | $255 |
| New patient visit (60+ min) | 26 | $4,658 | $179 |
| Study of rectum sensitivity and function | 13 | $3,309 | $255 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 52 | $2,285 | $34 |
| Testing for presence of drug, read by direct observation | 68 | $1,361 | $13 |
| Manual urinalysis test with examination using microscope, automated | 160 | $1,357 | $3 |
| Electronic assessment of bladder emptying | 62 | $581 | $8 |
2020: 16 services
| Return visit (30+ min) | 163 | $44,310 | $93 |
| Complete ultrasound scan of abdomen | 155 | $37,422 | $112 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 45 | $16,377 | $328 |
| Study of rectum sensitivity and function | 41 | $14,277 | $234 |
| Assessment of muscle signal of pelvic nerves | 45 | $10,913 | $232 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 11 | $8,603 | $717 |
| Long return visit (40+ min) | 49 | $7,026 | $115 |
| Testing for presence of drug, read by direct observation | 156 | $4,754 | $13 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 57 | $3,183 | $41 |
| New patient visit (45+ min) | 23 | $2,897 | $126 |
| Manual urinalysis test with examination using microscope, automated | 172 | $1,414 | $3 |
| Test or measurement for functional capacity, each 15 minutes | 12 | $919 | $32 |
| Electronic assessment of bladder emptying | 73 | $725 | $8 |
| Simple bladder irrigation and/or instillation | 12 | $553 | $39 |
| Application of electrical stimulation with therapist present, each 15 minutes | 12 | $293 | $10 |
| Injection of drug or substance under skin or into muscle | 16 | $255 | $13 |
2019: 19 services
| Complete ultrasound scan of abdomen | 206 | $41,890 | $104 |
| Return visit (30+ min) | 164 | $34,728 | $86 |
| Long return visit (40+ min) | 146 | $22,689 | $117 |
| Assessment of muscle signal of pelvic nerves | 90 | $22,353 | $203 |
| Study of rectum sensitivity and function | 67 | $17,219 | $210 |
| Critical care, first 30-74 minutes | 18 | $13,454 | $179 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 14 | $9,706 | $647 |
| Testing for presence of drug, read by direct observation | 180 | $4,224 | $12 |
| Critical care, each additional 30 minutes | 13 | $2,878 | $90 |
| Biofeedback training, perineal muscles, anorectal or urethral sphincter | 16 | $2,322 | $75 |
| New patient visit (45+ min) | 17 | $2,160 | $127 |
| Test or measurement for functional capacity, each 15 minutes | 20 | $1,577 | $30 |
| Manual urinalysis test with examination using microscope, automated | 209 | $1,490 | $3 |
| Electronic assessment of bladder emptying | 96 | $1,314 | $12 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $987 | $58 |
| Injection of drug or substance under skin or into muscle | 23 | $528 | $14 |
| Application of electrical stimulation with therapist present, each 15 minutes | 20 | $522 | $10 |
| Simple bladder irrigation and/or instillation | 13 | $453 | $32 |
| Insertion of needle into vein (3 years or older) | 17 | $265 | $15 |
2018: 13 services
| Complete ultrasound scan of abdomen | 190 | $58,719 | $108 |
| Return visit (30+ min) | 169 | $44,064 | $87 |
| Long return visit (40+ min) | 86 | $15,507 | $117 |
| Assessment of muscle signal of pelvic nerves | 66 | $14,500 | $188 |
| Critical care, first 30-74 minutes | 26 | $14,365 | $182 |
| Testing for presence of drug, read by direct observation | 186 | $7,479 | $13 |
| Critical care, each additional 30 minutes | 22 | $5,194 | $91 |
| New patient visit (45+ min) | 29 | $3,844 | $133 |
| Manual urinalysis test with examination using microscope, automated | 187 | $2,004 | $4 |
| New patient visit (60+ min) | 11 | $1,829 | $166 |
| Electronic assessment of bladder emptying | 95 | $1,478 | $13 |
| Injection of drug or substance under skin or into muscle | 24 | $664 | $18 |
| Insertion of needle into vein (3 years or older) | 22 | $328 | $14 |
2017: 20 services
| Complete ultrasound scan of abdomen | 213 | $55,400 | $102 |
| Return visit (30+ min) | 183 | $48,567 | $83 |
| Assessment of muscle signal of pelvic nerves | 94 | $20,598 | $178 |
| Long return visit (40+ min) | 111 | $18,898 | $112 |
| Critical care, first 30-74 minutes | 31 | $18,288 | $174 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 29 | $17,554 | $585 |
| Critical care, each additional 30 minutes | 24 | $6,600 | $88 |
| Complicated removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $6,055 | $336 |
| New patient visit (60+ min) | 36 | $5,435 | $151 |
| Testing for presence of drug, read by direct observation | 155 | $5,303 | $13 |
| Dilation of urethra using an endoscope | 16 | $4,079 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,637 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,728 | $160 |
| Manual urinalysis test with examination using microscope, automated | 210 | $2,522 | $4 |
| New patient visit (45+ min) | 19 | $2,327 | $122 |
| Electronic assessment of bladder emptying | 101 | $1,767 | $13 |
| Injection of drug or substance under skin or into muscle | 49 | $1,370 | $21 |
| Simple bladder irrigation and/or instillation | 28 | $884 | $30 |
| Limited ultrasound scan of pelvis | 22 | $880 | $40 |
| Insertion of needle into vein (3 years or older) | 21 | $279 | $13 |
2016: 16 services
| Complete ultrasound scan of abdomen | 274 | $58,500 | $107 |
| Return visit (30+ min) | 205 | $37,443 | $87 |
| Long return visit (40+ min) | 171 | $26,400 | $111 |
| Critical care, first 30-74 minutes | 36 | $25,673 | $185 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 31 | $18,818 | $607 |
| Assessment of muscle signal of pelvic nerves | 73 | $14,207 | $185 |
| Critical care, each additional 30 minutes | 24 | $9,161 | $93 |
| New patient visit (60+ min) | 45 | $7,392 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,453 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,029 | $168 |
| Manual urinalysis test with examination using microscope, automated | 272 | $2,369 | $4 |
| New patient visit (45+ min) | 16 | $1,964 | $123 |
| Electronic assessment of bladder emptying | 117 | $1,869 | $13 |
| Simple bladder irrigation and/or instillation | 27 | $1,007 | $36 |
| Injection of drug or substance under skin or into muscle | 35 | $861 | $22 |
| Insertion of needle into vein (3 years or older) | 26 | $395 | $15 |
2015: 18 services
| Complete ultrasound scan of abdomen | 273 | $55,424 | $108 |
| Return visit (30+ min) | 230 | $36,180 | $87 |
| Critical care, first 30-74 minutes | 29 | $21,551 | $187 |
| Long return visit (40+ min) | 139 | $21,219 | $115 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 28 | $17,804 | $614 |
| Assessment of muscle signal of pelvic nerves | 65 | $12,990 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $5,344 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,437 | $171 |
| New patient visit (60+ min) | 24 | $3,923 | $163 |
| New patient visit (45+ min) | 29 | $3,676 | $127 |
| Dilation of urethra using an endoscope | 15 | $3,569 | $238 |
| Critical care, each additional 30 minutes | 15 | $2,621 | $94 |
| Complicated insertion of bladder tube | 12 | $2,035 | $113 |
| Manual urinalysis test with examination using microscope, automated | 244 | $1,979 | $4 |
| Simple bladder irrigation and/or instillation | 29 | $1,164 | $36 |
| Electronic assessment of bladder emptying | 79 | $1,158 | $13 |
| Injection of drug or substance under skin or into muscle | 34 | $1,005 | $22 |
| Insertion of needle into vein (3 years or older) | 32 | $511 | $15 |
2014: 21 services
| Complete ultrasound scan of abdomen | 381 | $83,464 | $126 |
| Return visit (30+ min) | 339 | $56,229 | $87 |
| Long return visit (40+ min) | 148 | $22,667 | $117 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 35 | $21,787 | $605 |
| Assessment of muscle signal of pelvic nerves | 109 | $21,308 | $184 |
| Critical care, first 30-74 minutes | 30 | $16,342 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,781 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,282 | $170 |
| New patient visit (45+ min) | 42 | $5,417 | $129 |
| Dilation of urethra using an endoscope | 18 | $4,427 | $233 |
| New patient visit (60+ min) | 28 | $4,283 | $153 |
| Manual urinalysis test with examination using microscope, automated | 389 | $3,020 | $4 |
| Electronic assessment of bladder emptying | 145 | $2,119 | $12 |
| Complicated insertion of bladder tube | 12 | $2,008 | $112 |
| Limited ultrasound scan of abdomen | 18 | $1,732 | $96 |
| Injection of drug or substance under skin or into muscle | 55 | $1,702 | $22 |
| Simple bladder irrigation and/or instillation | 33 | $1,220 | $36 |
| Short return visit (20+ min) | 15 | $999 | $62 |
| Ultrasound scan of pelvic region through rectum | 11 | $907 | $82 |
| Ultrasound measurement of bladder capacity after voiding | 40 | $634 | $16 |
| Insertion of needle into vein (3 years or older) | 32 | $522 | $14 |
2013: 20 services
| Complete ultrasound scan of abdomen | 436 | $96,301 | $122 |
| Return visit (30+ min) | 400 | $74,777 | $88 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 37 | $23,341 | $614 |
| Long return visit (40+ min) | 133 | $18,050 | $113 |
| Assessment of muscle signal of pelvic nerves | 77 | $14,692 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $11,099 | $84 |
| Critical care, first 30-74 minutes | 22 | $9,717 | $180 |
| New patient visit (60+ min) | 48 | $7,662 | $160 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,874 | $164 |
| Dilation of urethra using an endoscope | 24 | $5,853 | $234 |
| New patient visit (45+ min) | 42 | $5,341 | $127 |
| Manual urinalysis test with examination using microscope, automated | 470 | $4,068 | $4 |
| Electronic assessment of bladder emptying | 191 | $2,971 | $12 |
| Injection of drug or substance under skin or into muscle | 57 | $2,575 | $23 |
| Short return visit (20+ min) | 37 | $2,546 | $61 |
| Needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $1,491 | $115 |
| New patient visit (30+ min) | 14 | $1,195 | $85 |
| Simple bladder irrigation and/or instillation | 28 | $1,037 | $36 |
| Ultrasound measurement of bladder capacity after voiding | 48 | $834 | $17 |
| Injection, garamycin, gentamicin, up to 80 mg | 49 | $45 | None |
Medicaid work
$180,263 in 2024
Medicaid paid $180,263 for 3,046 billed services this clinician did in 2024, up to 96 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 1,086 | $98,152 |
| Ultrasound, abdominal, real time with image documentation; complete | 593 | $46,069 |
| New patient visit (60+ min) | 107 | $12,465 |
| Measurement of bulbocavernosus reflex latency time | 63 | $9,274 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 38 | $9,040 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 1,029 | $2,303 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 92 | $1,632 |
| ANAL/URINARY MUSCLE STUDY | 38 | $1,329 |
| 2024 | 3,046 | 8 | 96 | $180,263 |
| 2023 | 4,026 | 8 | 113 | $240,127 |
| 2022 | 3,030 | 9 | 87 | $166,147 |
| 2021 | 2,265 | 11 | 89 | $112,347 |
| 2020 | 2,564 | 12 | 94 | $105,007 |
| 2019 | 3,167 | 12 | 126 | $119,864 |
| 2018 | 2,119 | 8 | 66 | $63,185 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 1,328 | $118,837 |
| Ultrasound, abdominal, real time with image documentation; complete | 683 | $53,968 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 1,450 | $18,927 |
| New patient visit (60+ min) | 191 | $17,022 |
| Measurement of bulbocavernosus reflex latency time | 138 | $16,458 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 54 | $10,357 |
| ANAL/URINARY MUSCLE STUDY | 56 | $2,302 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 126 | $2,256 |
2022
| Long return visit (40+ min) | 996 | $75,363 |
| Ultrasound, abdominal, real time with image documentation; complete | 550 | $44,219 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 1,025 | $17,277 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 73 | $9,709 |
| New patient visit (60+ min) | 133 | $8,735 |
| Measurement of bulbocavernosus reflex latency time | 31 | $4,712 |
| ANAL/URINARY MUSCLE STUDY | 74 | $2,877 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 134 | $2,154 |
| New patient visit (45+ min) | 14 | $1,102 |
2021
| Long return visit (40+ min) | 568 | $37,669 |
| Ultrasound, abdominal, real time with image documentation; complete | 455 | $35,740 |
| Return visit (30+ min) | 178 | $13,648 |
| Measurement of bulbocavernosus reflex latency time | 66 | $8,285 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 776 | $6,300 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 29 | $4,142 |
| New patient visit (45+ min) | 17 | $2,192 |
| New patient visit (60+ min) | 24 | $1,704 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 99 | $1,492 |
| ANAL/URINARY MUSCLE STUDY | 40 | $1,086 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 13 | $89 |
2020
| Return visit (30+ min) | 813 | $57,875 |
| Ultrasound, abdominal, real time with image documentation; complete | 418 | $17,136 |
| ANORECTAL MANOMETRY | 109 | $7,528 |
| New patient visit (45+ min) | 66 | $6,735 |
| Measurement of bulbocavernosus reflex latency time | 58 | $5,919 |
| ANAL/URINARY MUSCLE STUDY | 115 | $3,707 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 36 | $2,930 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 703 | $1,289 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 77 | $702 |
| PHYSICAL PERFORMANCE TEST | 58 | $597 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 53 | $306 |
| APPL MODALITY 1+ AREAS ESTIM EA 15 MIN | 58 | $285 |
2019
| Return visit (30+ min) | 969 | $63,452 |
| Ultrasound, abdominal, real time with image documentation; complete | 744 | $28,345 |
| New patient visit (45+ min) | 132 | $9,707 |
| Measurement of bulbocavernosus reflex latency time | 105 | $7,572 |
| ANORECTAL MANOMETRY | 100 | $5,443 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 187 | $2,754 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 840 | $1,356 |
| Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited | 18 | $456 |
| Long return visit (40+ min) | 21 | $398 |
| PHYSICAL PERFORMANCE TEST | 18 | $255 |
| APPL MODALITY 1+ AREAS ESTIM EA 15 MIN | 18 | $126 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 15 | $0 |
2018
| Return visit (30+ min) | 766 | $40,846 |
| Ultrasound, abdominal, real time with image documentation; complete | 465 | $8,147 |
| New patient visit (45+ min) | 97 | $6,127 |
| Measurement of bulbocavernosus reflex latency time | 26 | $3,251 |
| Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited | 86 | $2,764 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 93 | $1,236 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 515 | $815 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 71 | $0 |
Drugs they prescribed that Part D paid
$370,926
Pharmacies billed $370,926 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,924) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
1,578 generic and 346 brand-name prescriptions · $370,926 in drug cost · 177 antibiotic prescriptions to 108 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 205 | $144,812 | $706 |
| Myrbetriq | 102 | $51,566 | $506 |
| Orgovyx | 17 | $45,251 | $2,662 |
| Dutasteride | 343 | $14,258 | $42 |
| Tamsulosin | 449 | $6,461 | $14 |
See all 22 drugs
| Gemtesa | 205 | $144,812 | $706 |
| Myrbetriq | 102 | $51,566 | $506 |
| Orgovyx | 17 | $45,251 | $2,662 |
| Dutasteride | 343 | $14,258 | $42 |
| Tamsulosin | 449 | $6,461 | $14 |
| Alfuzosin Hcl Er | 129 | $2,521 | $20 |
| Finasteride | 152 | $1,906 | $13 |
| Estradiol | 31 | $1,755 | $57 |
| Testosterone | 14 | $1,003 | $72 |
| Bicalutamide | 23 | $990 | $43 |
| Oxybutynin Chloride Er | 47 | $754 | $16 |
| Nitrofurantoin Mono-Macro | 33 | $489 | $15 |
| Solifenacin | 17 | $477 | $28 |
| Nitrofurantoin | 16 | $347 | $22 |
| Terazosin | 23 | $327 | $14 |
| Clotrimazole | 24 | $259 | $11 |
| Levofloxacin | 81 | $207 | $3 |
| Amitriptyline | 47 | $189 | $4 |
| Cephalexin | 25 | $167 | $7 |
| Doxazosin Mesylate | 14 | $111 | $8 |
| Sildenafil Citrate | 32 | $76 | $2 |
| Ciprofloxacin | 15 | $54 | $4 |
Year by year
| 2024 | 1,924 | 408 | 0% (0) | 18% | $370,926 |
| 2023 | 1,988 | 396 | None | None | $452,316 |
| 2022 | 1,778 | 361 | 0% (0) | 20% | $376,324 |
| 2021 | 1,849 | 383 | None | 20% | $370,964 |
| 2020 | 1,995 | 383 | None | 15% | $342,792 |
| 2019 | 2,057 | 396 | 1% (23) | 16% | $401,288 |
| 2018 | 2,137 | 406 | 1% (24) | None | $174,592 |
| 2017 | 2,566 | 436 | 1% (26) | 13% | $362,888 |
| 2016 | 2,739 | 435 | 1% (37) | 17% | $327,504 |
| 2015 | 2,512 | 442 | 2% (45) | None | $304,762 |
| 2014 | 3,018 | 555 | 2% (66) | None | $284,719 |
| 2013 | 3,111 | 618 | 2% (62) | 47% | $288,008 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Myrbetriq | 251 | $139,012 | $554 |
| Gemtesa | 152 | $105,923 | $697 |
| Dutasteride | 288 | $29,284 | $102 |
| Tamsulosin | 473 | $14,091 | $30 |
| Solifenacin | 32 | $4,636 | $145 |
| Finasteride | 176 | $4,381 | $25 |
| Cialis | 12 | $4,095 | $341 |
| Oxybutynin Chloride Er | 80 | $3,171 | $40 |
| Estradiol | 23 | $2,794 | $121 |
| Alfuzosin Hcl Er | 48 | $2,538 | $53 |
| Tolterodine Tartrate Er | 11 | $2,314 | $210 |
| Testosterone | 17 | $2,278 | $134 |
| Bicalutamide | 33 | $1,977 | $60 |
| Desmopressin Acetate | 13 | $1,202 | $92 |
| Terazosin | 32 | $1,191 | $37 |
| Doxazosin Mesylate | 19 | $855 | $45 |
| Nitrofurantoin Mono-Macro | 21 | $733 | $35 |
| Testosterone Cypionate | 11 | $727 | $66 |
| Levofloxacin | 94 | $706 | $8 |
| Sildenafil Citrate | 17 | $493 | $29 |
| Cephalexin | 37 | $469 | $13 |
| Ciprofloxacin | 32 | $454 | $14 |
| Clotrimazole | 17 | $196 | $12 |
| Amitriptyline | 18 | $91 | $5 |
2022: 19 drugs
| Myrbetriq | 175 | $101,136 | $578 |
| Gemtesa | 121 | $74,147 | $613 |
| Dutasteride | 228 | $22,756 | $100 |
| Tamsulosin | 454 | $11,649 | $26 |
| Solifenacin | 34 | $4,390 | $129 |
| Finasteride | 157 | $2,704 | $17 |
| Testosterone | 14 | $2,494 | $178 |
| Estradiol | 17 | $2,161 | $127 |
| Oxybutynin Chloride Er | 63 | $2,048 | $33 |
| Bicalutamide | 47 | $1,903 | $40 |
| Sildenafil Citrate | 36 | $1,235 | $34 |
| Alfuzosin Hcl Er | 38 | $1,105 | $29 |
| Levofloxacin | 89 | $698 | $8 |
| Doxazosin Mesylate | 21 | $497 | $24 |
| Nitrofurantoin Mono-Macro | 11 | $454 | $41 |
| Cephalexin | 57 | $440 | $8 |
| Ciprofloxacin | 24 | $327 | $14 |
| Terazosin | 12 | $101 | $8 |
| Amitriptyline | 14 | $80 | $6 |
2021: 24 drugs
| Myrbetriq | 208 | $100,357 | $482 |
| Gemtesa | 83 | $48,265 | $582 |
| Dutasteride | 269 | $20,152 | $75 |
| Elmiron | 14 | $13,955 | $997 |
| Tamsulosin | 500 | $6,747 | $13 |
| Toviaz | 11 | $6,057 | $551 |
| Cialis | 12 | $4,159 | $347 |
| Testosterone | 17 | $4,096 | $241 |
| Finasteride | 123 | $2,658 | $22 |
| Oxybutynin Chloride Er | 63 | $2,203 | $35 |
| Estradiol | 11 | $2,002 | $182 |
| Tolterodine Tartrate Er | 16 | $1,496 | $93 |
| Bicalutamide | 44 | $1,480 | $34 |
| Desmopressin Acetate | 15 | $1,207 | $80 |
| Alfuzosin Hcl Er | 35 | $1,110 | $32 |
| Doxazosin Mesylate | 35 | $1,068 | $31 |
| Levofloxacin | 101 | $721 | $7 |
| Nitrofurantoin | 15 | $622 | $41 |
| Cephalexin | 45 | $420 | $9 |
| Sildenafil Citrate | 19 | $337 | $18 |
| Sulfamethoxazole-Trimethoprim | 25 | $268 | $11 |
| Terazosin | 18 | $138 | $8 |
| Ciprofloxacin | 27 | $133 | $5 |
| Lactulose | 13 | $110 | $8 |
2020: 29 drugs
| Xtandi | 11 | $139,214 | $12,656 |
| Myrbetriq | 175 | $81,737 | $467 |
| Dutasteride | 269 | $24,345 | $91 |
| Elmiron | 18 | $16,818 | $934 |
| Toviaz | 16 | $8,373 | $523 |
| Tamsulosin | 562 | $7,383 | $13 |
| Testosterone | 28 | $6,481 | $231 |
| Dutasteride-Tamsulosin | 15 | $4,197 | $280 |
| Cialis | 12 | $4,169 | $347 |
| Finasteride | 167 | $3,612 | $22 |
| Viagra | 11 | $3,139 | $285 |
| Oxybutynin Chloride Er | 78 | $3,050 | $39 |
| Tolterodine Tartrate Er | 18 | $1,586 | $88 |
| Alfuzosin Hcl Er | 61 | $1,533 | $25 |
| Solifenacin | 18 | $1,155 | $64 |
| Bicalutamide | 38 | $1,125 | $30 |
| Levofloxacin | 123 | $707 | $6 |
| Nitrofurantoin | 17 | $631 | $37 |
| Doxazosin Mesylate | 28 | $606 | $22 |
| Clotrimazole | 17 | $537 | $32 |
| Nitrofurantoin Mono-Macro | 12 | $461 | $38 |
| Ibuprofen | 16 | $295 | $18 |
| Cephalexin | 51 | $238 | $5 |
| Sildenafil Citrate | 16 | $202 | $13 |
| Terazosin | 20 | $180 | $9 |
| Lactulose | 16 | $158 | $10 |
| Ciprofloxacin | 16 | $106 | $7 |
| Sulfamethoxazole-Trimethoprim | 15 | $85 | $6 |
| Gabapentin | 13 | $66 | $5 |
2019: 24 drugs
| Lupron Depot | 42 | $66,236 | $1,577 |
| Myrbetriq | 126 | $55,479 | $440 |
| Dutasteride | 324 | $30,446 | $94 |
| Elmiron | 12 | $14,373 | $1,198 |
| Toviaz | 23 | $11,282 | $491 |
| Tamsulosin | 495 | $9,390 | $19 |
| Testosterone | 31 | $8,174 | $264 |
| Vesicare | 20 | $8,014 | $401 |
| Dutasteride-Tamsulosin | 22 | $5,099 | $232 |
| Cialis | 12 | $4,184 | $349 |
| Finasteride | 177 | $4,003 | $23 |
| Oxybutynin Chloride Er | 80 | $2,628 | $33 |
| Doxazosin Mesylate | 53 | $1,721 | $32 |
| Bicalutamide | 50 | $1,476 | $30 |
| Alfuzosin Hcl Er | 46 | $1,206 | $26 |
| Levofloxacin | 102 | $803 | $8 |
| Cephalexin | 55 | $451 | $8 |
| Ciprofloxacin | 30 | $411 | $14 |
| Hydrocodone-Acetaminophen | 13 | $350 | $27 |
| Pentoxifylline | 19 | $318 | $17 |
| Clotrimazole | 15 | $288 | $19 |
| Nortriptyline | 28 | $146 | $5 |
| Sulfamethoxazole-Trimethoprim | 21 | $132 | $6 |
| Terazosin | 13 | $97 | $7 |
2018: 19 drugs
| Dutasteride | 481 | $29,658 | $62 |
| Elmiron | 26 | $25,720 | $989 |
| Myrbetriq | 40 | $18,015 | $450 |
| Dutasteride-Tamsulosin | 73 | $12,904 | $177 |
| Vesicare | 24 | $12,364 | $515 |
| Tamsulosin | 573 | $10,044 | $18 |
| Cialis | 18 | $6,144 | $341 |
| Finasteride | 189 | $3,709 | $20 |
| Oxybutynin Chloride Er | 79 | $2,747 | $35 |
| Bicalutamide | 71 | $2,042 | $29 |
| Tolterodine Tartrate Er | 11 | $1,769 | $161 |
| Levofloxacin | 150 | $1,714 | $11 |
| Doxazosin Mesylate | 57 | $1,285 | $23 |
| Alfuzosin Hcl Er | 33 | $791 | $24 |
| Pentoxifylline | 35 | $425 | $12 |
| Cephalexin | 34 | $229 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $210 | $19 |
| Hydrocodone-Acetaminophen | 18 | $192 | $11 |
| Nortriptyline | 17 | $119 | $7 |
2017: 26 drugs
| Xtandi | 11 | $107,947 | $9,813 |
| Myrbetriq | 97 | $33,730 | $348 |
| Dutasteride-Tamsulosin | 126 | $18,936 | $150 |
| Dutasteride | 575 | $18,541 | $32 |
| Androgel | 31 | $17,592 | $567 |
| Cialis | 49 | $15,095 | $308 |
| Elmiron | 15 | $12,567 | $838 |
| Vesicare | 30 | $12,166 | $406 |
| Tamsulosin | 584 | $8,253 | $14 |
| Finasteride | 320 | $4,308 | $13 |
| Toviaz | 11 | $4,288 | $390 |
| Rapaflo | 14 | $3,266 | $233 |
| Tolterodine Tartrate Er | 22 | $3,114 | $142 |
| Levofloxacin | 190 | $2,153 | $11 |
| Oxybutynin Chloride Er | 62 | $1,904 | $31 |
| Bicalutamide | 48 | $933 | $19 |
| Doxazosin Mesylate | 29 | $698 | $24 |
| Alfuzosin Hcl Er | 39 | $612 | $16 |
| Cephalexin | 49 | $354 | $7 |
| Ciprofloxacin | 17 | $266 | $16 |
| Oxybutynin Chloride | 14 | $209 | $15 |
| Generlac | 14 | $201 | $14 |
| Hydrocodone-Acetaminophen | 22 | $181 | $8 |
| Sulfamethoxazole-Trimethoprim | 21 | $114 | $5 |
| Terazosin | 16 | $68 | $4 |
| Ssd | 11 | $39 | $4 |
2016: 30 drugs
| Xtandi | 14 | $126,094 | $9,007 |
| Myrbetriq | 133 | $39,876 | $300 |
| Dutasteride | 586 | $27,170 | $46 |
| Elmiron | 39 | $26,418 | $677 |
| Vesicare | 62 | $19,026 | $307 |
| Dutasteride-Tamsulosin | 102 | $14,807 | $145 |
| Cialis | 50 | $12,915 | $258 |
| Tamsulosin | 610 | $10,136 | $17 |
| Avodart | 50 | $8,228 | $165 |
| Rapaflo | 25 | $5,290 | $212 |
| Toviaz | 16 | $4,205 | $263 |
| Detrol La | 12 | $3,772 | $314 |
| Jalyn | 18 | $3,396 | $189 |
| Finasteride | 327 | $3,146 | $10 |
| Estrace | 11 | $2,969 | $270 |
| Levofloxacin | 211 | $2,104 | $10 |
| Bicalutamide | 51 | $1,558 | $31 |
| Doxazosin Mesylate | 28 | $757 | $27 |
| Alfuzosin Hcl Er | 51 | $682 | $13 |
| Cephalexin | 51 | $367 | $7 |
| Oxybutynin Chloride Er | 11 | $362 | $33 |
| Generlac | 20 | $301 | $15 |
| Ibuprofen | 18 | $272 | $15 |
| Nortriptyline | 23 | $224 | $10 |
| Pentoxifylline | 12 | $207 | $17 |
| Hydrocodone-Acetaminophen | 33 | $161 | $5 |
| Oxybutynin Chloride | 12 | $118 | $10 |
| Sulfamethoxazole-Trimethoprim | 18 | $110 | $6 |
| Terazosin | 14 | $105 | $8 |
| Diazepam | 20 | $29 | $1 |
2015: 27 drugs
| Avodart | 495 | $83,325 | $168 |
| Jalyn | 203 | $34,354 | $169 |
| Myrbetriq | 111 | $30,511 | $275 |
| Elmiron | 33 | $24,563 | $744 |
| Vesicare | 74 | $19,516 | $264 |
| Tamsulosin | 507 | $10,948 | $22 |
| Dutasteride | 67 | $8,514 | $127 |
| Rapaflo | 34 | $6,644 | $195 |
| Cialis | 21 | $4,609 | $219 |
| Finasteride | 219 | $2,194 | $10 |
| Levofloxacin | 185 | $2,068 | $11 |
| Trospium Chloride Er | 11 | $1,673 | $152 |
| Oxybutynin Chloride Er | 38 | $1,416 | $37 |
| Bicalutamide | 53 | $1,347 | $25 |
| Gabapentin | 14 | $896 | $64 |
| Alfuzosin Hcl Er | 66 | $837 | $13 |
| Doxazosin Mesylate | 27 | $622 | $23 |
| Hydrocodone-Acetaminophen | 31 | $403 | $13 |
| Cephalexin | 55 | $396 | $7 |
| Nitrofurantoin | 11 | $288 | $26 |
| Pentoxifylline | 12 | $214 | $18 |
| Sulfamethoxazole-Trimethoprim | 19 | $190 | $10 |
| Ibuprofen | 19 | $188 | $10 |
| Oxybutynin Chloride | 16 | $177 | $11 |
| Tramadol | 14 | $161 | $12 |
| Lorazepam | 11 | $36 | $3 |
| Diazepam | 11 | $16 | $1 |
2014: 30 drugs
| Avodart | 632 | $96,147 | $152 |
| Jalyn | 321 | $48,035 | $150 |
| Elmiron | 43 | $31,728 | $738 |
| Vesicare | 101 | $24,513 | $243 |
| Myrbetriq | 77 | $19,543 | $254 |
| Tamsulosin | 510 | $8,367 | $16 |
| Rapaflo | 50 | $8,048 | $161 |
| Toviaz | 24 | $4,513 | $188 |
| Levofloxacin | 260 | $4,332 | $17 |
| Finasteride | 235 | $3,281 | $14 |
| Viagra | 17 | $3,176 | $187 |
| Cialis | 13 | $2,249 | $173 |
| Alfuzosin Hcl Er | 89 | $1,856 | $21 |
| Oxybutynin Chloride Er | 42 | $1,755 | $42 |
| Bicalutamide | 66 | $1,730 | $26 |
| Doxazosin Mesylate | 41 | $881 | $21 |
| Nitrofurantoin | 19 | $779 | $41 |
| Oxybutynin Chloride | 43 | $623 | $14 |
| Cephalexin | 45 | $499 | $11 |
| Hydrocodone-Acetaminophen | 37 | $349 | $9 |
| Pentoxifylline | 19 | $342 | $18 |
| Gabapentin | 24 | $319 | $13 |
| Clotrimazole | 11 | $237 | $22 |
| Sulfamethoxazole-Trimethoprim | 26 | $226 | $9 |
| Ibuprofen | 24 | $206 | $9 |
| Tramadol | 22 | $189 | $9 |
| Lorazepam | 19 | $140 | $7 |
| Terazosin | 14 | $110 | $8 |
| Zolpidem | 14 | $103 | $7 |
| Diazepam | 16 | $33 | $2 |
2013: 31 drugs
| Avodart | 579 | $86,391 | $149 |
| Jalyn | 432 | $60,709 | $141 |
| Vesicare | 155 | $32,114 | $207 |
| Elmiron | 47 | $30,337 | $645 |
| Rapaflo | 93 | $13,323 | $143 |
| Tamsulosin | 477 | $7,369 | $15 |
| Toviaz | 37 | $6,242 | $169 |
| Levofloxacin | 284 | $5,686 | $20 |
| Finasteride | 237 | $5,101 | $22 |
| Uroxatral | 13 | $4,085 | $314 |
| Alfuzosin | 98 | $3,531 | $36 |
| Trospium Chloride Er | 20 | $3,241 | $162 |
| Enablex | 17 | $2,884 | $170 |
| Bicalutamide | 55 | $2,614 | $48 |
| Oxybutynin Chloride Er | 49 | $2,549 | $52 |
| Viagra | 17 | $2,536 | $149 |
| Pentoxifylline | 25 | $1,167 | $47 |
| Sulfamethoxazole-Trimethoprim | 63 | $575 | $9 |
| Oxybutynin Chloride | 32 | $371 | $12 |
| Doxazosin Mesylate | 30 | $368 | $12 |
| Phenazopyridine | 15 | $280 | $19 |
| Cephalexin | 12 | $243 | $20 |
| Ibuprofen | 24 | $234 | $10 |
| Tramadol | 21 | $216 | $10 |
| Ciprofloxacin | 18 | $208 | $12 |
| Lorazepam | 18 | $207 | $11 |
| Hydrocodone-Acetaminophen | 38 | $202 | $5 |
| Acyclovir | 11 | $152 | $14 |
| Imipramine | 13 | $106 | $8 |
| Terazosin | 20 | $103 | $5 |
| Amitriptyline | 15 | $55 | $4 |
Money from drug and device companies
$158 in 2025
| 2025 | 3 | 6 | None | $158 |
| 2024 | 6 | 20 | None | $525 |
| 2023 | 10 | 29 | None | $682 |
| 2022 | 7 | 17 | None | $328 |
| 2021 | 7 | 15 | None | $337 |
| 2020 | 2 | 3 | None | $58 |
| 2019 | 5 | 13 | None | $270 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Gemtesa | $114 | 4 payments
|
| Progenics Pharmaceuticals | Pylarify | $23 | 1 payment
|
| Pfizer | Xtandi | $21 | 1 payment
|
See all 6 published payments
| Sumitomo Pharma America | Meals · 2025-10-07 | Orgovyx | $27 |
| Sumitomo Pharma America | Meals · 2025-08-21 | Orgovyx | $27 |
| Pfizer | Meals · 2025-08-13 | Xtandi | $21 |
| Progenics Pharmaceuticals | Meals · 2025-06-18 | Pylarify | $23 |
| Sumitomo Pharma America | Meals · 2025-03-04 | Gemtesa | $31 |
| Sumitomo Pharma America | Meals · 2025-01-28 | Gemtesa | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $525
| Sumitomo Pharma America | Gemtesa | $290 | 10 payments
|
| Pfizer | Xtandi | $77 | 4 payments
|
| Progenics Pharmaceuticals | Pylarify | $50 | 2 payments
|
| Myriad Genetic Laboratories | Prolaris | $44 | 2 payments
|
| Merck Sharp & Dohme | Lynparza | $32 | 1 payment
|
| Abbvie | Botox | $31 | 1 payment
|
2023: $682
| Janssen Biotech | Erleada | $161 | 5 payments
|
| Sumitomo Pharma America | Gemtesa | $145 | 7 payments
|
| Progenics Pharmaceuticals | Pylarify | $67 | 3 payments
|
| Pfizer | Xtandi | $64 | 3 payments
|
| Myriad Genetic Laboratories | Prolaris | $51 | 2 payments
|
| Telix Pharmaceuticals | Illuccix | $48 | 2 payments
|
| AbbVie | Botox | $45 | 2 payments
|
| Astellas Pharma US | Xtandi | $41 | 2 payments
|
| Tolmar | Eligard | $39 | 2 payments
|
| GlaxoSmithKline | Shingrix | $22 | 1 payment
|
2022: $328
| Myriad Genetic Laboratories | Prolaris | $101 | 5 payments
|
| Pfizer | Xtandi | $66 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $47 | 3 payments
|
| Urovant Sciences | Gemtesa | $45 | 2 payments
|
| Abbvie | Lupron Depot | $34 | 2 payments
|
| Janssen Biotech | Erleada | $23 | 1 payment
|
| Boston Scientific | Rezum Generator | $12 | 1 payment
|
2021: $337
| Myriad Genetic Laboratories | Prolaris | $120 | 4 payments
|
| Astellas Pharma US | Xtandi | $63 | 3 payments
|
| Janssen Biotech | Erleada | $58 | 3 payments
|
| Pfizer | Xtandi | $40 | 2 payments
|
| Urovant Sciences | Gemtesa | $24 | 1 payment
|
| Lumenis | Lumenis Pulse 120h | $16 | 1 payment
|
| AbbVie | Lupron Depot | $15 | 1 payment
|
2020: $58
| Astellas Pharma US | Xtandi | $45 | 2 payments
|
| Coloplast | Continence Care | $13 | 1 payment
|
2019: $270
| Astellas Pharma US | Xtandi | $88 | 4 payments
|
| Janssen Biotech | Erleada | $69 | 4 payments
|
| NeoTract | Urolift | $53 | 2 payments
|
| Allergan | Botox | $46 | 2 payments
|
| Pfizer | Xtandi | $15 | 1 payment
|
Professional record
- NPI
- 1225053291
- Licence
- FL G74473
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G744730
- Taxonomy
- Urology (208800000X)
- Mailing address
- 1701 E Cesar E Chavez Ave, Suite 500, Los Angeles, CA, 90033
- NPI first listed
- 2006-07-12
- NPI last updated
- 2026-08-05
- NPI record certified
- 2026-08-05
This is when the NPI record was last certified, not a medical board exam.